title: Our experience about the particular surgical management of total hip replacement in two patients with severe haemophilic arthropathy: case report.
authors.forename: C
authors.initials: C
authors.lastname: Ruosi
authors.forename: D
authors.initials: D
authors.lastname: Rossi
authors.forename: A
authors.initials: A
authors.lastname: Coppola
authors.forename: S
authors.initials: S
authors.lastname: Liccardo
authors.forename: F
authors.initials: F
authors.lastname: Granata
authors.forename: A
authors.initials: A
authors.lastname: Barbato
authors.forename: E
authors.initials: E
authors.lastname: Cimino
authors.forename: M N D
authors.initials: MN
authors.lastname: Di Minno
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use; D001177:Arthropathy, Neurogenic / Q000150:complications / Q000175:diagnosis / Q000628:therapy*; D019644:Arthroplasty, Replacement, Hip; D004359:Drug Therapy, Combination; D006467:Hemophilia A / Q000150:complications*; D006526:Hepatitis C / Q000150:complications / Q000188:drug therapy; D006615:Hip / Q000000981:diagnostic imaging; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use; D008107:Liver Diseases / Q000175:diagnosis / Q000209:etiology; D008297:Male; D008875:Middle Aged; D011092:Polyethylene Glycols / Q000627:therapeutic use; D011859:Radiography; D011994:Recombinant Proteins / Q000627:therapeutic use; D012254:Ribavirin / Q000627:therapeutic use; D012720:Severity of Illness Index
chemical_list: D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin; C417083:peginterferon alfa-2b